Eprenetapopt/Azacitidine Combo Elicits Promising Activity in TP53-Mutant MDS and AML
OncLive,
The combination of eprenetapopt and azacitidine demonstrated a promising safety profile as well as encouraging clinical…
The combination of eprenetapopt and azacitidine demonstrated a promising safety profile as well as encouraging clinical…
Advertisement Kamal Menghrajani, MD Martin S. Tallman, MD Although several treatment options are available for patients with…
Myelodysplastic syndromes are a heterogeneous group of stem cell disorders that have been associated with a variety of…